CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes

Cytokine

Volumn 44, Issue 1, 2008, Pages 154-159

  Stalvey, Michael S ^a   Brusko, Todd M ^a   Mueller, Christian ^a   Wasserfall, Clive H ^a   Schatz, Desmond A ^a   Atkinson, Mark A ^a   Flotte, Terence R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

CFTR; Cystic fibrosis; Diabetes; IL 10; Inflammation

Indexed keywords

GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; STREPTOZOCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DIABETES MELLITUS; FEMALE; HYPERGLYCEMIA; IMMUNOREACTIVITY; MALE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; UPREGULATION;

ANIMALS; CELL PROLIFERATION; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; HYPERGLYCEMIA; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKINS; MALE; MICE; MICE, INBRED CFTR; TH2 CELLS;

ANIMALIA; MURINAE; MUS;

EID: 52949126348     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.07.468     Document Type: Article

References (53)

1. Boat F. Chapter 393-cystic fibrosis. Nelson textbook of pediatrics. 17th ed. (2004), Behrman p. 1437-1450
2. Shwachman H., Leubner H., and Catzel P. Mucoviscidosis. Adv Pediatr 7 (1955) 249-323
3. Foundation CF. Patient Registry 2005 Annual Report. Bethesda, MD; 2006.
4. Orenstein D.M., Winnie G.B., and Altman H. Cystic fibrosis: a 2002 update. J Pediatr 140 2 (2002) 156-164
5. Lanng S. Glucose intolerance in cystic fibrosis patients. Paediatr Respir Rev 2 3 (2001) 253-259
6. Hardin D.S., and Moran A. Diabetes mellitus in cystic fibrosis. Endocrinol Metab Clin North Am 28 4 (1999) 787-800 ix
7. Milla C.E., Warwick W.J., and Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 162 3 Pt. 1 (2000) 891-895
8. Milla C.E., Billings J., and Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 28 9 (2005) 2141-2144
9. Johnston J.A., Ward C.L., and Kopito R.R. Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143 7 (1998) 1883-1898
10. Xu Y., Clark J.C., Aronow B.J., Dey C.R., Liu C., Wooldridge J.L., et al. Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J Biol Chem 278 9 (2003) 7674-7682
11. Virella-Lowell I., Herlihy J.D., Liu B., Lopez C., Cruz P., Mueller C., et al. Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell line. Mol Ther 10 3 (2004) 562-573
12. Venkatakrishnan A., Stecenko A.A., King G., Blackwell T.R., Brigham K.L., Christman J.W., et al. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 23 3 (2000) 396-403
13. Lory S., and Ichikawa J.K. Pseudomonas-epithelial cell interactions dissected with DNA microarrays. Chest 121 Suppl. 3 (2002) 36S-39S
14. Kirchner K.K., Wagener J.S., Khan T.Z., Copenhaver S.C., and Accurso F.J. Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis. Am J Respir Crit Care Med 154 5 (1996) 1426-1429
15. Heeckeren A., Walenga R., Konstan M.W., Bonfield T., Davis P.B., and Ferkol T. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 100 11 (1997) 2810-2815
16. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 12 (2005) 953-964
17. Di A., Brown M.E., Deriy L.V., Li C., Szeto F.L., Chen Y., et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 8 9 (2006) 933-944
18. Saini L.S., Galsworthy S.B., John M.A., and Valvano M.A. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology 145 Pt. 12 (1999) 3465-3475
19. Maloney K.E., and Valvano M.A. The mgtC gene of Burkholderia cenocepacia is required for growth under magnesium limitation conditions and intracellular survival in macrophages. Infect Immun 74 10 (2006) 5477-5486
20. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25 12 (2004) 677-686
21. Hartl D., Griese M., Kappler M., Zissel G., Reinhardt D., Rebhan C., et al. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol 117 1 (2006) 204-211
22. Mueller C., Braag S.A., Herlihy J.D., Wasserfall C.H., Chesrown S.E., Nick H.S., et al. Enhanced IgE allergic response to Aspergillus fumigatus in CFTR-/- mice. Lab Invest 86 2 (2006) 130-140
23. Zuercher A.W., Imboden M.A., Jampen S., Bosse D., Ulrich M., Chtioui H., et al. Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine. Clin Exp Immunol 143 1 (2006) 132-138
24. Montolio M., Tellez N., Soler J., and Montanya E. Role of blood glucose in cytokine gene expression in early syngeneic islet transplantation. Cell Transplant 16 5 (2007) 517-525
25. Wen Y., Gu J., Li S.L., Reddy M.A., Natarajan R., and Nadler J.L. Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages. Endocrinology 147 5 (2006) 2518-2525
26. Leonidou L., Mouzaki A., Michalaki M., DeLastic A.L., Kyriazopoulou V., Bassaris H.P., et al. Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. J Infect 55 4 (2007) 340-346
27. Stalvey M.S., Mueller C., Schatz D.A., Wasserfall C.H., Campbell-Thompson M.L., Theriaque D.W., et al. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after β-cell injury. Diabetes 55 7 (2006) 1939-1945
28. Snouwaert J.N., Brigman K.K., Latour A.M., Malouf N.N., Boucher R.C., Smithies O., et al. An animal model for cystic fibrosis made by gene targeting. Science 257 5073 (1992) 1083-1088
29. Zhou L., Dey C.R., Wert S.E., DuVall M.D., Frizzell R.A., and Whitsett J.A. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science 266 5191 (1994) 1705-1708
30. Ito M., Kondo Y., Nakatani A., Hayashi K., and Naruse A. Characterization of low dose streptozotocin-induced progressive diabetes in mice. Environ Toxicol Pharmacol 9 3 (2001) 71-78
31. Terheggen-Lagro S.W., Rijkers G.T., and van der Ent C.K. The role of airway epithelium and blood neutrophils in the inflammatory response in cystic fibrosis. J Cyst Fibros 4 Suppl. 2 (2005) 15-23
32. Conese M., Copreni E., Di Gioia S., De Rinaldis P., and Fumarulo R. Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease. J Cyst Fibros 2 3 (2003) 129-135
33. Sagel S.D., and Accurso F.J. Monitoring inflammation in CF cytokines. Clin Rev Allergy Immunol 23 1 (2002) 41-57
34. Berger M. Inflammatory mediators in cystic fibrosis lung disease. Allergy Asthma Proc 23 1 (2002) 19-25
35. Mueller C., Torrez D., Braag S., Martino A., Clarke T., Campbell-Thompson M., et al. Partial correction of the CFTR-dependent ABPA mouse model with recombinant adeno-associated virus gene transfer of truncated CFTR gene. J Gene Med 10 1 (2008) 51-60
36. Muhlebach M.S., Reed W., and Noah T.L. Quantitative cytokine gene expression in CF airway. Pediatr Pulmonol 37 5 (2004) 393-399
37. Becker M.N., Sauer M.S., Muhlebach M.S., Hirsh A.J., Wu Q., Verghese M.W., et al. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 169 5 (2004) 645-653
38. Moss R.B., Hsu Y.P., and Olds L. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin Exp Immunol 120 3 (2000) 518-525
39. Casaulta C., Schoni M.H., Weichel M., Crameri R., Jutel M., Daigle I., et al. IL-10 controls Aspergillus fumigatus- and Pseudomonas aeruginosa-specific T-cell response in cystic fibrosis. Pediatr Res 53 2 (2003) 313-319
40. + T cells. J Immunol 160 7 (1998) 3188-3193
41. Cohen S.B., Katsikis P.D., Feldmann M., and Londei M. IL-10 enhances expression of the IL-2 receptor alpha chain on T cells. Immunology 83 3 (1994) 329-332
42. Chen W.F., and Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 147 2 (1991) 528-534
43. Taga K., Cherney B., and Tosato G. IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int Immunol 5 12 (1993) 1599-1608
44. Cohen S.B., Crawley J.B., Kahan M.C., Feldmann M., and Foxwell B.M. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology 92 1 (1997) 1-5
45. Janeway C., Travers P., Walport M., and Shlomchik M. Immunobiology. 6th ed. (2005), Garland Science Publishing, New York, NY
46. Antoniv T.T., Park-Min K.H., and Ivashkiv L.B. Kinetics of IL-10-induced gene expression in human macrophages. Immunobiology 210 2-4 (2005) 87-95
47. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T.M., Atkinson M.A., et al. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 165 3 (2004) 1045-1053
48. Wasmuth H.E., Kunz D., Graf J., Stanzel S., Purucker E.A., Koch A., et al. Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-alpha. Crit Care Med 32 5 (2004) 1109-1114
49. Liu S., Tinker L., Song Y., Rifai N., Bonds D.E., Cook N.R., et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 167 15 (2007) 1676-1685
50. Rush E.C., Plank L.D., and Yajnik C.S. Interleukin-6, tumour necrosis factor-alpha and insulin relationships to body composition, metabolism and resting energy expenditure in a migrant Asian Indian population. Clin Endocrinol (Oxf) 66 5 (2007) 684-690
51. Calcinaro F., Gambelunghe G., and Lafferty K.J. Protection from autoimmune diabetes by adjuvant therapy in the non-obese diabetic mouse: the role of interleukin-4 and interleukin-10. Immunol Cell Biol 75 5 (1997) 467-471
52. Zhang Y.C., Molano R.D., Pileggi A., Powers M., Cross J., Wasserfall C., et al. Adeno-associated virus transduction of islets with interleukin-4 results in impaired metabolic function in syngeneic marginal islet mass transplantation. Transplantation 74 8 (2002) 1184-1186
53. Mueller R., Lee M.S., Sawyer S.P., and Sarvetnick N. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes. J Autoimmun 9 2 (1996) 151-158